Vivo Capital IX, LLC, 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 400 shares at $30.37 ($12K) on 2021-04-14, disclosed to the SEC on 2021-04-16.
Open-market sale of $12k TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2021-06-25 | $5.9M | — | Filing → |
| TARS | SELL | 2021-06-25 | $1.9M | — | Filing → |